Hailong Zhang's research while affiliated with Henan Medical University and other places

Publications (9)

Article
Objective: To assess the completeness of reporting in randomized controlled trials (RCTs) of acupuncture therapy (AT) for chronic obstructive pulmonary disease (COPD). Methods: We systematically searched PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), Chongqing VIP (CQVIP), WANFANG Data, and Chin...
Article
Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is the leading cause of morbidity and mortality in COPD management. However, detecting the progression from the stable stage to acute exacerbation mainly depends on doctors’ judgment of clinical symptoms, and there is no biomarker that can be used for auxiliary clinical diagnosis....
Article
Full-text available
Objective: To evaluate the efficacy and safety of early pulmonary rehabilitation (PR) (ie, <3 days of hospitalization) in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods: Embase, Web of Science, PubMed and Cochrane Library were searched from their inception to 1 April 2021. Randomized controlled trials...
Article
Full-text available
Background and objective IPF is a chronic progressive lung disease in which PR provides benefit for patients. PD, a TCM PR programme, has known effectiveness in COPD, but its utility in IPF is unknown. We investigated its effectiveness and safety in patients with IPF. Methods A 6‐month randomized controlled trial (RCT) was conducted in three Chine...
Article
Full-text available
Purpose: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is an essential occurrence in COPD management and is the leading cause of morbidity and mortality. Chinese herbal medicine is widely used in the treatment of AECOPD, but high quality randomized controlled trials are limited. This study aimed to evaluate the efficacy and...
Preprint
Full-text available
Background: At present, there is short of effective treatment for acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF). The treatment of IPF with Traditional Chinese medicine (TCM) has some advantages. However, the evidence is unclear whether TCM can be recommended as an effective therapy to treat AE-IPF. The purpose of the study is to expl...
Article
Full-text available
Objective: The role of telemonitoring interventions (TIs) for chronic obstructive pulmonary disease (COPD) has been studied in many systematic reviews (SRs) and meta-analyses (MAs), but robust conclusions have not been reached due to wide variations in scopes, qualities, and outcomes. The aim of this overview was to determine the effectiveness of...
Article
Full-text available
Background: The incidence, mortality, and prevalence of chronic obstructive pulmonary disease (COPD) are high in China. Acute exacerbations of COPD (AECOPD) are important events in the management of COPD because they negatively impact health status, rates of hospitalization and readmission, and disease progression. AECOPD have been effectively tre...
Article
Full-text available
Background and objective Pulmonary Daoyin (PD) (evolved from ancient Chinese daoyin skills), is a rehabilitation technology that combines specially designed movements of the arms and body and controlled breathing exercises, to improve the physiological and psychological status of patients with chronic respiratory disease. Pulmonary rehabilitation i...

Citations

... Traditional Chinese medicine (TCM), characterised by the theory of syndrome differentiation and overall conditioning, implies its potential advantages in the treatment of COPD. A systematic review has revealed that TCM combined with conventional medicines could accelerate the relief of clinical symptoms in COPD patients and improve lung function, modified British medical research council (mMRC), COPD assessment test (CAT), Saint George's respiratory questionnaire (SGRQ), 6-minute walking distance (6MWD), BMI, obstruction, dyspnoea, exercise capacity (BODE) score, and COPD patient-reported outcomes (COPD-PRO) to improve the quality of life and reduce the frequency of acute exacerbations and hospitalisation duration of AECOPD patients [12,13]. Moreover, studies on TCM syndrome have found that in addition to respiratory symptoms, such as cough, phlegm, and wheezing, patients in acute exacerbation often experience constipation, abdominal distension, and yellow greasy tongue coating. ...
... Studies have shown that Daoyin can reduce the risk factors of cardiovascular disease, alleviate COPD and improve idiopathic pulmonary fibrosis. [12][13][14] In China, Daoyin has been widely used in the treatment of lumbar disc herniation as an effective complementary therapy. [15] Although massage has been considered as an effective complementary therapy for LDH, [8,16] the methodological and reporting quality of relevant meta-analysis is still not optimistic, which is difficult to provide high-quality reference evidence for clinicians. ...
... One limitation of systematic reviews is that they are not necessarily contemporary, and thus more recent individual studies may not be represented in this review. It is important to note that evaluating methodological or evidence quality using the AMSTAR 2 tool is a subjective process and although the included systematic reviews and meta-analyses have been evaluated independently by two researchers, there may still be some bias [122]. Finally, it is important to acknowledge that this report does not include a full representation of the grey literature, as this was well beyond scope. ...
... Studies have shown that Daoyin can reduce the risk factors of cardiovascular disease, alleviate COPD and improve idiopathic pulmonary fibrosis. [12][13][14] In China, Daoyin has been widely used in the treatment of lumbar disc herniation as an effective complementary therapy. [15] Although massage has been considered as an effective complementary therapy for LDH, [8,16] the methodological and reporting quality of relevant meta-analysis is still not optimistic, which is difficult to provide high-quality reference evidence for clinicians. ...